Author Arora, Prerna

1 to 20 of 29 Items
  • 2019 | Journal Article | 
    ​ ​A system for production of defective interfering particles in the absence of infectious influenza A virus​
    Bdeir, N.; Arora, P.; Gärtner, S.; Hoffmann, M.; Reichl, U.; Pöhlmann, S. & Winkler, M.​ (2019) 
    PlOS ONE, 14(3) art. e0212757​.​ DOI: https://doi.org/10.1371/journal.pone.0212757 
    ​Details  DOI  PMID  PMC 
  • 2021 | Journal Article
    ​ ​SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination​
    Hoffmann, M.; Hofmann-Winkler, H.; Krüger, N.; Kempf, A.; Nehlmeier, I.; Graichen, L. & Arora, P. et al.​ (2021) 
    Cell Reports, 36(3) art. S2211124721008287​.​ DOI: https://doi.org/10.1016/j.celrep.2021.109415 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination​
    Arora, P.; Sidarovich, A.; Krüger, N.; Kempf, A.; Nehlmeier, I.; Graichen, L. & Moldenhauer, A.-S. et al.​ (2021) 
    Cell Reports, 37(2) art. S2211124721012894​.​ DOI: https://doi.org/10.1016/j.celrep.2021.109825 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies​
    Hoffmann, M.; Arora, P.; Groß, R.; Seidel, A.; Hörnich, B. F.; Hahn, A. S. & Krüger, N. et al.​ (2021) 
    Cell, 184(9) pp. 2384​-2393.e12​.​ DOI: https://doi.org/10.1016/j.cell.2021.03.036 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity​
    Hoffmann, M.; Hofmann-Winkler, H.; Smith, J. C.; Krüger, N.; Arora, P.; Sørensen, L. K. & Søgaard, O. S. et al.​ (2021) 
    EBioMedicine, 65 art. 103255​.​ DOI: https://doi.org/10.1016/j.ebiom.2021.103255 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles​
    Hein, M. D.; Arora, P.; Marichal-Gallardo, P.; Winkler, M.; Genzel, Y.; Pöhlmann, S. & Schughart, K. et al.​ (2021) 
    BMC Biology, 19(1) art. 91​.​ DOI: https://doi.org/10.1186/s12915-021-01020-5 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity​
    Bdeir, N.; Arora, P.; Gärtner, S.; Pöhlmann, S. & Winkler, M.​ (2021) 
    Scientific Reports, 11(1) art. 20477​.​ DOI: https://doi.org/10.1038/s41598-021-99691-1 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Mutation D614G increases SARS-CoV-2 transmission​
    Arora, P.; Pöhlmann, S. & Hoffmann, M.​ (2021) 
    Signal Transduction and Targeted Therapy, 6(1).​ DOI: https://doi.org/10.1038/s41392-021-00502-w 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Sidarovich, A.; Winkler, M. S. & Schulz, S. et al.​ (2021) 
    Cellular & Molecular Immunology, 18(11) pp. 2557​-2559​.​ DOI: https://doi.org/10.1038/s41423-021-00772-y 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency​
    Arora, P.; Rocha, C.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S. & Lier, M. et al.​ (2021) 
    Cellular & Molecular Immunology, 18(12) pp. 2673​-2675​.​ DOI: https://doi.org/10.1038/s41423-021-00779-5 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3​
    Arora, P.; Zhang, L.; Rocha, C.; Sidarovich, A.; Kempf, A.; Schulz, S. & Cossmann, A. et al.​ (2022) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(22)00224-9 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein​
    Arora, P.; Sidarovich, A.; Graichen, L.; Hörnich, B.; Hahn, A.; Hoffmann, M. & Pöhlmann, S.​ (2022) 
    PLoS One, 17(3) art. e0265453​.​ DOI: https://doi.org/10.1371/journal.pone.0265453 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy​
    Hoffmann, M.; Sidarovich, A.; Arora, P.; Krüger, N.; Nehlmeier, I.; Kempf, A. & Graichen, L. et al.​ (2022) 
    mBio,.​ DOI: https://doi.org/10.1128/mbio.00364-22 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S.; Lier, M. & Schulz, S. et al.​ (2022) 
    Cell Reports, art. S2211124722005186​.​ DOI: https://doi.org/10.1016/j.celrep.2022.110754 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Cossmann, A.; Stankov, M. V & Jäck, H.-M. et al.​ (2022) 
    The Lancet Infectious Diseases, 22(8) pp. 1117​-1118​.​ DOI: https://doi.org/10.1016/S1473-3099(22)00422-4 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Understanding Omicron: Transmissibility, immune evasion and antiviral intervention​
    Hoffmann, M.; Arora, P. & Pöhlmann, S.​ (2022) 
    Clinical and Translational Medicine, 12(5).​ DOI: https://doi.org/10.1002/ctm2.839 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Omicron sublineage BQ.1.1 resistance to monoclonal antibodies​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Jäck, H.-M.; Pöhlmann, S. & Hoffmann, M.​ (2022) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(22)00733-2 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75​
    Arora, P.; Nehlmeier, I.; Kempf, A.; Cossmann, A.; Schulz, S. R; Dopfer-Jablonka, A. & Baier, E. et al.​ (2022) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(22)00591-6 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies​
    Arora, P.; Zhang, L.; Krüger, N.; Rocha, C.; Sidarovich, A.; Schulz, S. & Kempf, A. et al.​ (2022) 
    Cell Host & Microbe, 30(8) pp. 1103​-1111.e6​.​ DOI: https://doi.org/10.1016/j.chom.2022.04.017 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S.; Lier, M. & Schulz, S. et al.​ (2022) 
    Cellular & Molecular Immunology,.​ DOI: https://doi.org/10.1038/s41423-021-00811-8 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100